New drug deal to deliver savings of €400 million
The Department of Health, the HSE and the pharmaceutical industry have reached a new three-year agreement on drug prices which is expected to deliver more than €400 million in savings.
The Department of Health, the HSE and the pharmaceutical industry have reached a new three-year agreement on drug prices which is expected to deliver more than €400 million in savings.
The deal with the Irish Pharmaceutical Healthcare Association (IPHA) will reduce the cost of drugs for patients, lower the drugs bill for the state and lead to greater access to new cutting-edge drugs, the Department of Health said.
It will also ease financial pressure on...
Subscribe from just €1 for the first month!
What's Included
With any subscription you will have access to
-
Unlimited multi-device access to our iPad, iPhone and Android Apps
-
Unlimited access to our eReader library
-
Exclusive daily insight and opinion seven days a week
-
Create alerts to never miss a subject that matters to you
-
Get access to exclusive offers for subscribers on gifts and experiences
-
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
